NIH-funded research NIH-funded research

Stroger Hospital Cancer Care and Clinical Trials Program

Official title: Stroger Hospital of Cook County (SHCC) NCORP

Funded at Cook County Health and Hospital System · NIH-11336963 · Data updated 2026-11-12

This program brings NCI-approved cancer clinical trials, prevention, and survivorship services to patients served by Cook County Health in Chicago, with a focus on urban and African American communities.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCook County Health and Hospital System
NIH-funded
Lab location1 site (Chicago, United States)
Project startAugust 16, 2014
Project endJuly 31, 2026
Funding year2025
Award (this year)$916,936
NIH project number3UG1CA190000-12S1
Project IDNIH-11336963 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people receiving cancer care within the Cook County Health system in Chicago—especially urban and African American patients with breast, brain, lung, prostate, gastrointestinal, hematologic, head and neck, or gynecologic cancers—who are willing to consider clinical trials or participate in prevention and survivorship programs.

Less likely to help

Patients who do not receive care at Stroger Hospital or affiliated Cook County clinics, or who are not eligible or willing to join clinical trials or donate samples, are unlikely to directly benefit from this program.

What this research studies

At Stroger Hospital and its affiliated clinics, this program connects patients to clinical trials across many cancer types and to cancer control and survivorship activities offered locally. The site works with NCI research bases to open trials, coordinate care, and collect annotated blood and tissue samples for translational studies. It partners with CountyCare and local providers to improve access, quality of oncology care, and implementation of process improvements. As a patient you could enroll in trials, access prevention and survivorship programs, or donate samples to research while receiving care in your community.

Why it matters

Potential benefit: If successful, the program could expand access to new treatments and improve prevention, survivorship, and outcomes for underserved cancer patients in Cook County.

How similar studies have gone: Other NCORP community programs have successfully increased trial access and enrollment in underserved populations, and this award continues that established model.

Where this research is happening

  • Cook County Health and Hospital System
    Chicago, United States
    Active

Researchers

  • Principal investigator: Tamkus, Deimante — Cook County Health and Hospital System
  • Study coordinator: Tamkus, Deimante

Related research

Other NIH-funded projects on the same topics.

  • Stroger Hospital NCORP: Cancer care and research network in Chicago

    A local cancer center in Chicago partners with national networks to bring better cancer care, prevention, and trials to patients, especially in African American communities.

    NIH research Cook County Health and Hospital System · Chicago, United States · NIH-11543559

  • Improving cancer care for underserved populations in Chicago

    This study is all about improving cancer care for African Americans and other underserved communities by making sure they have access to the latest treatments and support right in their neighborhoods, helping them live healthier lives and fight cancer more effectively.

    NIH research Cook County Health and Hospital System · Chicago, United States · NIH-11270438

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.